Compile Data Set for Download or QSAR
maximum 50k data
Found 1473 with Last Name = 'plattner' and Initial = 'jj'
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

Curated by ChEMBL
LigandPNGBDBM50099843((S)-N-[(S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino...)
Affinity DataKi:  0.00100nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

Curated by ChEMBL
LigandPNGBDBM578((2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)aceta...)
Affinity DataKi:  0.00100nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
TargetGag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

Curated by ChEMBL
LigandPNGBDBM50099842((S)-N-[(S)-4-[2-(2,6-Dimethyl-phenoxy)-acetylamino...)
Affinity DataKi:  0.00100nMAssay Description:Inhibitory activity against HIV proteaseMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM194((5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(4-hydroxy-...)
Affinity DataKi:  0.00500nM ΔG°:  -65.6kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM195((5R,6R)-1,5-dibenzyl-2-(cyclopropylmethyl)-6-hydro...)
Affinity DataKi:  0.0620nM ΔG°:  -59.2kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM192((5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(4-hydroxyp...)
Affinity DataKi:  0.0700nM ΔG°:  -58.9kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM189((5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis({[4-(hydrox...)
Affinity DataKi:  0.220nM ΔG°:  -56.0kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM193((5R,6R)-1,5-dibenzyl-6-hydroxy-2,4-bis[(3-methoxyp...)
Affinity DataKi:  0.220nM ΔG°:  -56.0kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM190((5R,6R)-2,4-Bis[4-(hydroxymethyl)benzyl]-1-(3-fura...)
Affinity DataKi:  0.490nM ΔG°:  -54.0kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM191((5R,6R)-1,2,4,5-tetrabenzyl-6-hydroxy-1,2,4-triaze...)
Affinity DataKi:  2nM ΔG°:  -50.5kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDimer of Gag-Pol polyprotein [489-587](Human immunodeficiency virus type 1)
Abbott Laboratories

LigandPNGBDBM196(A-74704 | CHEMBL307193 | benzyl N-[(1S)-1-{[(2S,4S...)
Affinity DataKi:  4.5nM ΔG°:  -48.4kJ/molepH: 4.7 T: 2°CAssay Description:HIV-1 protease activity was measured by a continuous fluorometric assay using the internally quenched fluorogenic substrate DABCYL-GABA-Ser-Gln-Tyr-P...More data for this Ligand-Target Pair
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339869(5-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl...)
Affinity DataKi:  20nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339868(4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl...)
Affinity DataKi:  20nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339870(2-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl...)
Affinity DataKi:  80nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339846(6-phenoxybenzo[c][1,2]oxaborol-1(3H)-ol | CHEMBL17...)
Affinity DataKi:  710nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339856(6-(3-methoxyphenoxy)benzo[c][1,2]oxaborol-1(3H)-ol...)
Affinity DataKi:  1.35E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339862(3-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl...)
Affinity DataKi:  1.44E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Saccharomyces cerevisiae S288c)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50370987(TAVABOROLE)
Affinity DataKi:  1.85E+3nMAssay Description:Inhibition of Saccharomyces cerevisiae cytoplasmic leucyl-tRNA synthetase after 20 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339860(6-(3-(benzyloxy)phenoxy)benzo[c][1,2]oxaborol-1(3H...)
Affinity DataKi:  2.27E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339857(6-(3-aminophenoxy)benzo[c][1,2]oxaborol-1(3H)-ol |...)
Affinity DataKi:  2.75E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339859(6-(3-(aminomethyl)phenoxy)benzo[c][1,2]oxaborol-1(...)
Affinity DataKi:  3.33E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339855(6-(phenylamino)benzo[c][1,2]oxaborol-1(3H)-ol | CH...)
Affinity DataKi:  4.73E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339867(CHEMBL1761273 | ethyl 4-(1-hydroxy-1,3-dihydrobenz...)
Affinity DataKi:  5.55E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339863(6-(4-methoxyphenoxy)benzo[c][1,2]oxaborol-1(3H)-ol...)
Affinity DataKi:  6.00E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339850(6-(hydroxy(phenyl)methyl)benzo[c][1,2]oxaborol-1(3...)
Affinity DataKi:  7.28E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339861(6-(3-((dimethylamino)methyl)phenoxy)benzo[c][1,2]o...)
Affinity DataKi:  7.72E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339858(6-(3-(hydroxymethyl)phenoxy)benzo[c][1,2]oxaborol-...)
Affinity DataKi:  8.40E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339864(6-(4-aminophenoxy)benzo[c][1,2]oxaborol-1(3H)-ol |...)
Affinity DataKi:  8.73E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339847(6-(phenylthio)benzo[c][1,2]oxaborol-1(3H)-ol | CHE...)
Affinity DataKi:  9.09E+3nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339865(6-(4-(aminomethyl)phenoxy)benzo[c][1,2]oxaborol-1(...)
Affinity DataKi:  1.33E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339854(6-((phenylaminooxy)carbonyl)benzo[c][1,2]oxaborol-...)
Affinity DataKi:  1.60E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339848(6-benzylbenzo[c][1,2]oxaborol-1(3H)-ol | CHEMBL176...)
Affinity DataKi:  1.98E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339849((1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-6-yl)(...)
Affinity DataKi:  2.85E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetLeucine--tRNA ligase, cytoplasmic(Saccharomyces cerevisiae S288c)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50370987(TAVABOROLE)
Affinity DataKi:  3.14E+4nMAssay Description:Inhibition of Saccharomyces cerevisiae cytoplasmic leucyl-tRNA synthetase after 2 minsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339866(6-(4-((dimethylamino)methyl)phenoxy)benzo[c][1,2]o...)
Affinity DataKi:  4.06E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339853(CHEMBL1761258 | N-(1-hydroxy-1,3-dihydrobenzo[c][1...)
Affinity DataKi:  4.66E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339851(6-(phenylsulfinyl)benzo[c][1,2]oxaborol-1(3H)-ol |...)
Affinity DataKi:  5.80E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetBeta-lactamase(Enterobacter cloacae)
Anacor Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50339852(6-(phenylsulfonyl)benzo[c][1,2]oxaborol-1(3H)-ol |...)
Affinity DataKi:  6.32E+4nMAssay Description:Inhibition of Enterobacter cloacae P99 beta-lactamase AmpC P99 using nitrocefin as substrate after 30 mins by spectrophotometric analysisMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 208 |...)
Affinity DataIC50:  0.0500nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetcAMP-dependent protein kinase catalytic subunit alpha(Homo sapiens (Human))
Anacor Pharmaceuticals

US Patent
LigandPNGBDBM258601(US9493490, 6-(4-(aminomethyl)-2-chlorophenoxy)-7-i...)
Affinity DataIC50:  0.0550nMT: 2°CAssay Description:Phosphorylation of activity of ROCK1 and ROCK2 and those of other kinases, AKT1, GRK2, PKA, PKCa and RSK1 were performed by Reaction Biology (Malvern...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 208 |...)
Affinity DataIC50:  0.120nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRibosomal protein S6 kinase alpha-1(Homo sapiens (Human))
Anacor Pharmaceuticals

US Patent
LigandPNGBDBM258601(US9493490, 6-(4-(aminomethyl)-2-chlorophenoxy)-7-i...)
Affinity DataIC50:  0.195nMT: 2°CAssay Description:Phosphorylation of activity of ROCK1 and ROCK2 and those of other kinases, AKT1, GRK2, PKA, PKCa and RSK1 were performed by Reaction Biology (Malvern...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589753(US11559538, Example 16 | US11559538, Example 208 |...)
Affinity DataIC50:  0.220nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589895(US11559538, Example 147 | US11559538, Example 148)
Affinity DataIC50:  0.240nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589886(US11559538, Example 138 | US11559538, Example 139 ...)
Affinity DataIC50:  0.25nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589754(US11559538, Example 17 | US11559538, Example 50)
Affinity DataIC50:  0.280nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589803(US11559538, Example 60 | US11559538, Example 61 | ...)
Affinity DataIC50:  0.280nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetRenin(Homo sapiens (Human))
Abbott Laboratories

Curated by ChEMBL
LigandPNGBDBM50022647(2-Benzyl-N-[1-(1-cyclohexylmethyl-2,3-dihydroxy-5-...)
Affinity DataIC50:  0.290nMpH: 6.0Assay Description:Inhibition of purified human renin (pH 6.0)More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetIsoform PDE4B2 of cAMP-specific 3',5'-cyclic phosphodiesterase 4B(Homo sapiens (Human))
Pfizer

US Patent
LigandPNGBDBM589830(US11559538, Example 84 | US11559538, Example 85)
Affinity DataIC50:  0.290nMAssay Description:Cytokine inhibitory activity is determined by measuring the effect of test agent on the release of the cytokines IL-4, IL-13 and IFNγ from human...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetInterleukin-4(Human)
Pfizer

US Patent
LigandPNGBDBM589948(US11559538, Example 195 | US11559538, Example 196)
Affinity DataIC50:  0.290nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 1473 total ) | Next | Last >>
Jump to: